<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Clinical and Experimental Medicine</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EABC601B-917B-4973-A947-5641893A00B1"><gtr:id>EABC601B-917B-4973-A947-5641893A00B1</gtr:id><gtr:firstName>Gavin</gtr:firstName><gtr:otherNames>D</gtr:otherNames><gtr:surname>Perkins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/FD52AA0E-162B-48A6-A3D8-73DB58D8566F"><gtr:id>FD52AA0E-162B-48A6-A3D8-73DB58D8566F</gtr:id><gtr:firstName>Fang</gtr:firstName><gtr:surname>Gao</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D9183B33-AD3A-434E-B7C1-98C64E802C0A"><gtr:id>D9183B33-AD3A-434E-B7C1-98C64E802C0A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>Thickett</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1100196"><gtr:id>575C81F0-0D6E-4F8A-BACF-553E12C4582E</gtr:id><gtr:title>Developmental Clinical Studies - development of vitamin D therapy to prevent acute lung injury.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100196</gtr:grantReference><gtr:abstractText>The aim of this research is to develop vitamin D as a therapy to prevent acute lung injury. Acute lung injury ALI is a major cause of lung failure in critically ill patients. Most patients affected are of working age and survivors experience a significant reduction in health-related quality of life, with 46% unable to return to work within 12 months. Currently, apart from invasive protective ventilation, no therapy has been conclusively proven to reduce mortality or improve functional outcome in survivors. This represents a major unmet health need. 
By undertaking this research we will establish if simple and cheap replacement of vitamin D influences the development and severity of acute lung injury.</gtr:abstractText><gtr:technicalSummary>ALI is a major cause of respiratory failure in critically ill patients. Most patients affected are of working age and survivors experience a significant reduction in health-related quality of life, with 46% unable to return to work within 12 months. Currently, apart from protective ventilation strategies, no therapy has been conclusively proven to reduce mortality or improve functional outcome in survivors. Clearly this represents a major unmet health need.

ALI is the final common pathway of response to a variety of direct pulmonary insults such as bacterial /viral pneumonia and gastric aspiration, or indirect insults such as abdominal sepsis or battlefield trauma. However, only a relatively small proportion of patients develop ALI, with research suggesting that genetic, demographic (age), social (smoking, alcohol abuse) and other factors play a role in determining who develops ALI. 

Patients undergoing transthoracic oesophagectomy are at significant risk of developing post operative lung injury (~28%), with the development of lung injury associated with a doubling of in hospital stay and significant mortality.Hospital episode statistics show that ~1500 to 2000 oesophagectomies are performed in England annually. There are no current readily available tests that can clearly identify those who are at high risk of ALI following oesophagectomy, and no therapeutic interventions proven to prevent its occurrence.

Epidemiological studies have suggested a role for vitamin D deficiency in the risk of developing both viral and bacterial infection. Vitamin D has profound effects on human immunity acting as an immune system modulator, preventing excessive expression of inflammatory cytokines and increasing the ?oxidative burst? potential of macrophages, therefore enhancing bacterial killing. In preliminary studies we have found that vitamin D deficiency/ insufficiency is ubiquitous in both patients with ALI and oesophagectomy cases who are at risk of ALI. Severe deficiency is associated with elevated systemic inflammatory response and an increased risk of developing lung injury in the oesophagectomy group. 

This proposal aims in a series of clinical studies to determine the proof of concept and optimal dosing strategy for administering cholecalciferol liquid preoperatively to prevent lung injury in oesophagectomy using established markers of bioactivity /efficacy in the setting of ALI. 

The proposed treatment is simple and if effective could be easily incorporated into widespread clinical practice. The results from this trial will provide the basis for future clinical studies investigating this and other preventative strategies in broader subject groups known to be at risk of ARDS such as pneumonia and sepsis.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>490752</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of East Anglia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of East Anglia</gtr:description><gtr:id>138C0DC8-B391-46A7-8C80-631A3FA4D5CF</gtr:id><gtr:impact>all in progress still</gtr:impact><gtr:partnerContribution>provide expertise and high value equipment access to enable tandem mass spec and DEQAS controlled ELISA</gtr:partnerContribution><gtr:piContribution>This collaboration was set up to appropriately measure vitamin D levels in the clinical samples from the vindaloo trial</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>mrc entry training mr/j011266/1</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>mr/j011266/1</gtr:fundingRef><gtr:id>46E75321-20D3-4FEE-89B8-C574258EF12B</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Intensive care society Young investigator Award</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Intensive Care Society</gtr:fundingOrg><gtr:id>FDBFA2DA-D6AE-4DA9-AB8F-7D1C87AE63BD</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>we are currently testing this in the clinical trials funded by the mrc</gtr:description><gtr:id>828BE3C6-6E24-45D8-9EA5-08534376826E</gtr:id><gtr:impact>we have established the dose to use for patients undergoing oesophagectomy to replace vitamin d preoperatively</gtr:impact><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>vitamin d</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:ukcrnIsctnId>ISRCTN27673620</gtr:ukcrnIsctnId><gtr:url>http://www.controlled-trials.com/ISRCTN27673620</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A6742E93-00CF-4AF5-BB26-4878C5910F25"><gtr:id>A6742E93-00CF-4AF5-BB26-4878C5910F25</gtr:id><gtr:title>Vitamin D Deficiency in Human and Murine Sepsis.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f47126a4ec394fd920c7841461c30850"><gtr:id>f47126a4ec394fd920c7841461c30850</gtr:id><gtr:otherNames>Parekh D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/480744AF-D50F-4D36-A6B0-DD87346F6F68"><gtr:id>480744AF-D50F-4D36-A6B0-DD87346F6F68</gtr:id><gtr:title>Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5d469eef458d3b36f2fe9265f5c853f3"><gtr:id>5d469eef458d3b36f2fe9265f5c853f3</gtr:id><gtr:otherNames>Moazed F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/71650B82-21C2-444D-90BC-620908E0D605"><gtr:id>71650B82-21C2-444D-90BC-620908E0D605</gtr:id><gtr:title>Vitamin D deficiency and acute lung injury.</gtr:title><gtr:parentPublicationTitle>Inflammation &amp; allergy drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f47126a4ec394fd920c7841461c30850"><gtr:id>f47126a4ec394fd920c7841461c30850</gtr:id><gtr:otherNames>Parekh D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1871-5281</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CDA169CD-6BC6-43EF-8A19-CD4DE4925A1E"><gtr:id>CDA169CD-6BC6-43EF-8A19-CD4DE4925A1E</gtr:id><gtr:title>Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS).</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4172d5af2705259b5de8213021df2b87"><gtr:id>4172d5af2705259b5de8213021df2b87</gtr:id><gtr:otherNames>Dancer RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/792D2595-5F00-4A01-B4FF-A0844F702956"><gtr:id>792D2595-5F00-4A01-B4FF-A0844F702956</gtr:id><gtr:title>Evidence for chemokine synergy during neutrophil migration in ARDS.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4caedb66bcfc1d4fcbe856af47164bdd"><gtr:id>4caedb66bcfc1d4fcbe856af47164bdd</gtr:id><gtr:otherNames>Williams AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76FC32F1-02EF-471F-81E4-19B6A347F7D5"><gtr:id>76FC32F1-02EF-471F-81E4-19B6A347F7D5</gtr:id><gtr:title>Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection.</gtr:title><gtr:parentPublicationTitle>Disease markers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13925804e8caf7ce4484516cdd2d9611"><gtr:id>13925804e8caf7ce4484516cdd2d9611</gtr:id><gtr:otherNames>Lugg ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0278-0240</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/10D6E517-0619-444E-B99F-02AF376DAD17"><gtr:id>10D6E517-0619-444E-B99F-02AF376DAD17</gtr:id><gtr:title>The impact of the acute respiratory distress syndrome on outcome after oesophagectomy.</gtr:title><gtr:parentPublicationTitle>British journal of anaesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2684758afd23d231f1a53589a73eb49e"><gtr:id>2684758afd23d231f1a53589a73eb49e</gtr:id><gtr:otherNames>Howells P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-0912</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB5671DD-26D4-453E-9486-78C099A7EE2C"><gtr:id>DB5671DD-26D4-453E-9486-78C099A7EE2C</gtr:id><gtr:title>Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f47126a4ec394fd920c7841461c30850"><gtr:id>f47126a4ec394fd920c7841461c30850</gtr:id><gtr:otherNames>Parekh D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4D9A1A63-64CC-4642-A241-E517F659407C"><gtr:id>4D9A1A63-64CC-4642-A241-E517F659407C</gtr:id><gtr:title>Association between prehospital vitamin D status and incident acute respiratory failure in critically ill patients: a retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ open respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/866bce9233d2b6b77489b005830b9d00"><gtr:id>866bce9233d2b6b77489b005830b9d00</gtr:id><gtr:otherNames>Thickett DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2052-4439</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100196</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>4F7FE31F-D266-4FE9-9BAB-3D21E9B789BA</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.3  Nutrition and chemoprevention</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>